Payer feedback is recurring faster than product evidence can be compared.
Commercial urgency protects account momentum while source traceability protects reusable product decisions.
Who you’d be doing this for
“I’ve heard three versions of the same concern this month, and I still don’t know what changed.”
Eleonora Moretti · Behavioral Health Network Executive
A health-plan buyer who relies on payer-facing reporting to assess outpatient behavioral health network performance.
What is at stake
Repeated payer requests are arriving with different language, so recurring needs are hard to separate from one-off asks. You have to weigh fast clustering against the evidence PMs need to trust a theme.
Why it isn’t already fixed
Every obvious fix costs something else. That’s the part you’d have to decide.
- commercial speed vs source-backed product evidence
- open-ended discovery vs measurable evaluation
- reusable patterns vs account-specific context
- AI clustering vs PM judgment
Why Headway
Payer-facing data products must turn health-plan questions about outcomes, cost, and network performance into evidence that can be reused across accounts.
Written with these in mind
Not your kind of problem? 75 more at Headway, or browse every organization.
This is the setup. The work is inside.
Running it puts you in the room: the full situation and its constraints, stakeholders who push back in their own words, and the decisions that are yours to make. What you produce becomes a Day One Plan — work you can show someone instead of describing.